Thomas Najarian
Los Osos, CANPI 1023033115
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $2,184,625 of the $2,184,625 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Vivus LLC.
Across 21 payments — averaging $104,030 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vivus LLC$2.2M
What the payments were for
- Royalty or licence$2,184,625100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vivus LLC | 21 | $2,184,625 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QSYMIA$2,184,625
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.